Stanford computer scientist James Zou and colleagues published Paper2Agent in Nature on September 16, an open-source framework that converts academic papers and their codebases into runnable AI agents…
A new Nature paper by Jiacheng Miao, Joe R. Davis, Yaohui Zhang, Jonathan K. Pritchard, and James Zou introduces Paper2Agent, an automated framework that converts research papers into artificial intel…
Stanford researchers Jiacheng Miao and James Zou published Paper2Agent in Nature on September 16, a system that converts a research paper's methods, code and data into an MCP server other agents can c…
Stanford University computer scientist James Zou and his team published a paper in Nature describing Paper2Agent, an AI tool that converts a research paper into a paper-specific AI agent hosted on an …
Stanford Medicine researchers Jiacheng Miao and James Zou published Paper2Agent in Nature, a framework that converts research papers, code, and datasets into Model Context Protocol (MCP) servers so ma…
Jiacheng Miao and James Zou published Paper2Agent in Nature on September 16, a six-stage multi-agent pipeline that converts a scientific paper, its code and supporting data into a Model Context Protoc…
A method published in Nature on September 16, 2026 by Stanford authors Jiacheng Miao, Joe R. Davis, Yaohui Zhang, Jonathan Pritchard and James Zou converts research papers and their code repositories …
An AI detector scored a passage from Mary Shelley's 1818 novel Frankenstein as 99% AI generated, while six other detectors unanimously classified the same text as human-written, highlighting the unrel…
Researchers from Harvard University and the Massachusetts Institute of Technology (MIT) launched MatrAIx, an AI evaluation infrastructure containing 8.3 billion AI personas, each defined across 1,290 …
A study by researchers including Aneesh Pappu and James Zou found that self-organizing multi-agent LLM teams fail to match the performance of their best individual expert, with losses up to 41.1% on M…
Stanford University researchers built coordinated multi-agent AI systems that function as virtual biotech companies, generating dozens of novel drug candidates in days instead of months. In one demons…